LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that more t…
Author: Business Wire
Nordic Group B.V., par l’intermédiaire de sa filiale Nordic Pharma, Inc. (U.S.), nomme un chirurgien oculoplastique de renom, John P. Fezza, MD, au sein de son conseil consultatif médical
BERWYN, Pennsylvanie–(BUSINESS WIRE)–Nordic Pharma, Inc., une filiale de Nordic Group B.V., annonce aujourd’hui que l’éminent chirurgien oculoplastique John P. Fezza, MD, intégrera son conseil consultatif médical (MAB) aux États-Unis, qui comprend Er…
OneLegacy Partnered with Danny Trejo and Trejo Music to Host SOULDIEZ Concert Featuring Talented Artists, Lowriders, Trejo’s Tacos and More
LOS ANGELES–(BUSINESS WIRE)–OneLegacy Inspires Hollywood partnered with Danny Trejo and Trejo Music to present SOULDIEZ, a music concert that took place at the OneLegacy’s Headquarters in Azusa with the goal of sharing the power of music with the cri…
Nordic Group B.V. ernennt über die Tochtergesellschaft Nordic Pharma, Inc. (USA) den anerkannten Augenchirurgen John P. Fezza, MD zum Mitglied des Medical Advisory Board
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc., eine Tochtergesellschaft der Nordic Group B.V., hat heute bekannt gegeen, dass der bekannte okuloplastische Chirurg John P. Fezza, MD zum Mitglied ihres U.S. Medical Advisory Board (MAB) ernannt wurde….
Riassunto: Nordic Group B.V., tramite la sua affiliata Nordic Pharma, Inc. (U.S.), nomina il rinomato chirurgo oculoplastico John P. Fezza, MD, membro del Consiglio di consulenza medica
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc., un’affiliata di Nordic Group B.V. oggi ha annunciato che l’eminente chirurgo oculoplastico John P. Fezza, MD, entrerà a far parte del Consiglio di consulenza medica che include Eric Donnenfeld, MD (New…
Resumen: Nordic Group B.V. a través de su filial Nordic Pharma, Inc. (EE. UU.), nombra al prestigioso cirujano oculoplástico John P. Fezza, miembro de su Junta asesora médica
BERWYN, Pensilvania–(BUSINESS WIRE)–Nordic Pharma, Inc, filial de Nordic Group B.V., ha anunciado hoy que el prestigioso cirujano oculoplástico John P. Fezza, formará parte de su Junta asesora médica (MAB, por sus siglas en inglés) en Estados Unidos….
Samenvatting: Via haar dochteronderneming Nordic Pharma, Inc. (U.S.) benoemt Nordic Group B.V. de vermaarde oculoplastische chirurg John P. Fezza, MD, tot lid van haar Medische Adviesraad
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc., een dochteronderneming van Nordic Group B.V., maakte vandaag bekend dat de eminente oculoplastische chirurg John P. Fezza, MD, zal zetelen in haar MAB in de V.S. (Medical Advisory Board = Medische Advi…
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board
BERWYN, Pa.–(BUSINESS WIRE)–Nordic Pharma, Inc. announced today that eminent oculoplastic surgeon John P. Fezza, MD will serve on its U.S. Medical Advisory Board (MAB).
OcuTerra Announces Topline Data from Phase 2 DR:EAM Trial Evaluating Nesvategrast (OTT166 5%) for Patients with Diabetic Retinopathy
BOSTON–(BUSINESS WIRE)–OcuTerra Therapeutics announces topline data from the Phase 2 DR:EAM clinical trial.
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces that the Company has entered into an agreement to sell its DERMAd…
Surface Ophthalmics Announces New Leadership with Richard Lindstrom, MD, and Renewed Vision for Addressing Critical Unmet Needs of Dry Eye Syndrome Patients
PLEASANTON, Calif.–(BUSINESS WIRE)–Surface Ophthalmics, a pioneering biopharmaceutical company, dedicated to transforming the management and treatment of dry eye syndrome (DES), today announced the appointment of Richard Lindstrom, MD as Founder &…
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
National Vision Awards Trio of Optometry Students $12,500 in Ninth Annual Scholarship Program
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the largest optical retail companies in the U.S. providing quality, affordable eye care and eyewear, announced today the winners of its ninth annual scholarship program, fueling the success of…
STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment …
US Eye Chief Medical Officer Dr. Kerry Solomon Honored with AECOS Award
BRADENTON, Fla.–(BUSINESS WIRE)– #AECOS–The American-European Congress of Ophthalmic Surgery (AECOS) has named Kerry Solomon, M.D. as the 2024 recipient of its prestigious Dulaney Award.
Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India
BENGALURU, India–(BUSINESS WIRE)–The release will introduce Alcon’s latest Intraocular Lens technology in India
GenSight Biologics Announces Initial Results from New Meta-Analyses on Visual Outcomes with LUMEVOQ® Gene Therapy at NANOS 2024
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)—- $GRPH #GraphiteBio–Graphite Bio, Inc. (Nasdaq: GRPH) (“Graphite” or the “Company”) today announced that its Board of Directors has declared a special dividend in connection with the previously announced…
Nordic Eyewear Market Insights & Forecasts Report 2024-2028 with Competitive Analysis of Grand Vision, Synsam, Specsavers, Synologen, Optik Team, and Krogh Optikk – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Nordic Eyewear Market (Sweden, Denmark, Norway & Finland): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)” report has been added to ResearchAndMarkets.com’s offering. The Nordic eyewear market is…